Star Combo Pharma (ASX:S66) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Star Combo Pharma 3-Year EBITDA Growth Rate?

Star Combo Pharma's EBITDA per Share for the six months ended in Dec. 2024 was A$0.00.

During the past 12 months, Star Combo Pharma's average EBITDA Per Share Growth Rate was 46.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Star Combo Pharma was 64.30% per year. The lowest was -17.50% per year. And the median was 23.40% per year.

Competitive Comparison of Star Combo Pharma's 3-Year EBITDA Growth Rate

For the Household & Personal Products subindustry, Star Combo Pharma's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Star Combo Pharma's 3-Year EBITDA Growth Rate Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Star Combo Pharma's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Star Combo Pharma's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Star Combo Pharma 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Star Combo Pharma (ASX:S66) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Star Combo Pharma 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Star Combo Pharma's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Star Combo Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Star Combo Pharma Ltd (ASX:S66) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

171 - 177 Woodpark Road, Smithfield, Sydney, NSW, AUS, 2164

Website

https://www.starcombo.com.au

Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as face masks, moisturizing creams, serums, concentrates, and oils. Star Combo Pharma markets its products. It operates in two segments. Star Combo segment engages in the development, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment has made up of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers; and Koala Mall's two retail stores in Sydney. Geographically, it operates in China and Australia.

Star Combo Pharma Headlines

No Headlines